KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Keunchil Park

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 12건 중 1-12 번을 표시중입니다.

1 Article A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data Parneet Cheema ; Byoung Chul Cho ; Helano Freitas ; et al 2023
2 Article Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study 김상위 ; Amy Roshak ; Byoung Chul Cho ; et al 2021
3 Article Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions Caicun Zhou ; Ke-Jing Tang ; Byoung Chul Cho ; et al 2023
4 Article Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial Byoung Chul Cho ; Dong-Wan Kim ; Alexander I Spira ; et al 2023
5 Article CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Treated Patients With Advanced T790M-Negative EGFR-Mutated NSCLC: A Brief Report Dong-Wan Kim ; Sang-We Kim ; D Ross Camidge ; et al 2023
6 Article Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis Byoung Chul Cho ; Dong-Wan Kim ; Ullas Batra ; et al 2023
7 Article Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations. 김상위 ; Agnieszka Cseh ; Christina Raabe ; et al 2021
8 Article Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study 이대호 ; Adrian Langleben ; Ayman Samkari ; et al 2021
9 Article Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer 이대호 ; Bo H Chao ; David Planchard ; et al 2021
10 Article Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive EGFR-mutant Non-small Cell Lung Cancer 이대호 ; Bo H Chao ; David Planchard ; et al 2021
11 Article Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis 김상위 ; Byoung Chul Cho ; Cheol Hyeon Kim ; et al 2020
12 Article The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients 김상위 ; Ahmad Awada ; Alain Thibault ; et al 2021

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.